Supportive Care for Patients With Hematological Malignancies Undergoing Hematopoietic Cell Transplant
|Hematopoietic/Lymphoid Cancer||Other: palliative care Other: questionnaire administration Procedure: quality-of-life assessment|
|Study Design:||Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
|Official Title:||FEASIBILITY OF IMPLEMENTING PRE-TRANSPLANT EVALUATION BY THE SUPPORTIVE CARE TEAM FOR PATIENTS UNDERGOING HEMATOPOIETIC CELL TRANSPLANTATION FOR HEMATOLOGICAL MALIGNANCIES|
- Study participation rates defined as the proportion of patients who consent to enroll [ Time Frame: Up to 5 months ]Will mainly be descriptive.
- Completion time for the supportive care consultation [ Time Frame: Up to 90 days post-treatment ]Will mainly be descriptive.
- Level of comfort / distress attributed to individual parts of the consultation [ Time Frame: Up to 90 days post-treatment ]Will mainly be descriptive. The post-consultation scores measuring level of comfort or distress per topic in the supportive care consultation will be summarized per item.
- Completeness of follow-up data collection, where completeness is defined by the proportion of instrument scores that can be calculated per given time point [ Time Frame: Up to 90 days post-treatment ]Will mainly be descriptive. The completeness of follow-up data collection will be calculated and reported as a proportion of successfully completed scales vs. scales attempted to be collected or completed by patients.
|Study Start Date:||April 2013|
|Primary Completion Date:||November 2014 (Final data collection date for primary outcome measure)|
Experimental: Supportive care (palliative care support)
Patients undergo palliative care support before transplantation and at least once monthly while they remain at the transplant center.
Other: palliative care
Undergo supportive care interventionOther: questionnaire administration
Ancillary studiesProcedure: quality-of-life assessment
Other Name: quality of life assessment
I. Pilot a supportive care intervention that begins prior to transplantation and continues through the acute peritransplant period.
II. Determine the proportion of patients who enroll and the level of comfort / distress of hematopoietic cell transplant (HCT) patients who meet with the supportive care team.
III. Pilot data collection mechanisms and cost retrieval in preparation for a randomized clinical trial.
Patients undergo supportive care consultation before transplantation and at least once monthly while they remain at the transplant center.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01758484
|United States, Washington|
|Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium|
|Seattle, Washington, United States, 98109|
|Principal Investigator:||Stephanie Lee||Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium|